| Document |
Document Title |
|
WO/2019/001473A1 |
Provided are a dendritic polyglycol derivative, a preparation method therefor, and an application thereof. The dendritic polyglycol derivative has a structure of formula (I), a plurality of terminal functional groups, and better water so...
|
|
WO/2018/230848A1 |
The present specification relates to a compound in chemical formula (1), a coating composition comprising the compound in chemical formula (1), an organic light-emitting device using same and a method for preparing same.
|
|
WO/2018/223347A1 |
Disclosed is a method for synthesizing an N-alkylaminophenyl alkyl ether, wherein the N-alkylaminophenyl alkyl ether is prepared by subjecting a nitrophenyl alkyl ether to hydrogenation reduction and alkylation, or wherein same may also ...
|
|
WO/2018/219204A1 |
The present invention relates to a novel phenoxyacetic acid derivative represented by general formula (I), a preparation method for the derivative and uses of drug compositions containing the derivative in drug preparation for treatment ...
|
|
WO/2018/211844A1 |
This compound is represented by general formula (1). In general formula (1), R1 and R2 are each independently an alkyl group having 1 to 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, an aryl group having 6 to 14 carbon atom...
|
|
WO/2018/213140A1 |
Disclosed herein are compounds of Formulae (la), (lb), (Ic), (Id), (le), (If), (Ig), (Ih), (Ik), (Im), (In), (Io), (Ip), (Iq), (Ir), (Is) and (It), methods of synthesizing compounds of Formulae (la), (lb), (Ic), (Id), (le), (If), (Ig), (...
|
|
WO/2018/213281A1 |
The present disclosure relates to novel compounds, pharmaceutical compositions containing the compounds and methods of using the compounds and pharmaceutical compositions for treating neurodegerative diseases, including Alzheimer's disea...
|
|
WO/2018/210738A1 |
An absorbent for the selective removal of hydrogen sulfide from a fluid stream comprising carbon dioxide and hydrogen sulfide, wherein the absorbent contains an aqueous solution, comprising:a) an amine or a mixture of amines of the gener...
|
|
WO/2018/207120A1 |
The present invention is directed towards a process for the preparation of 4- fluoro-2-methoxy-5-nitroaniline (I) or salts thereof, wherein, 4-fluoro-2-methoxy aniline (III) is protected to obtain N-protected-(4-fiuoro-2-methoxy)aniline ...
|
|
WO/2018/202681A1 |
The invention is in the technical field of insect control and relates to the use of a disubstituted benzenes for controlling insecticide-resistant pests such as mosquitoes and cockroaches.
|
|
WO/2018/186040A1 |
Provided is an ionic liquid, characterized in containing a cationic component and an anionic component, and in that the cationic component comprises a group having a perfluoropolyether chain and a group having a hydroxyl group.
|
|
WO/2018/174442A1 |
The present invention relates to a compound for treating diseases caused by a coronavirus infection. The compound exhibits excellent inhibitory activity against coronaviruses, and is useful as a pharmaceutical composition for preventing ...
|
|
WO/2018/167264A1 |
The present invention relates to a phenalene-1-one compound, a photosensitizer composition comprising said phenalene-1-one compound, an article comprising said phenalene-1-one compound and/or photosensitizer composition and the use thereof.
|
|
WO/2018/159933A1 |
The present specification relates to a fluorine-based compound in chemical formula (1), a coating composition comprising the fluorine-based compound in chemical formula (1), an organic light-emitting device using same and a method for pr...
|
|
WO/2018/158674A1 |
The present invention is in relation to a process of preparation of asymmetric synthesis of Rivastigmine and its salts in high yield and purity.
|
|
WO/2018/159937A1 |
The present specification relates to a fluorine-based compound in chemical formula (1), a coating composition comprising the fluorine-based compound in chemical formula (1), an organic light-emitting device using same and a method for pr...
|
|
WO/2018/143923A1 |
The present disclosure is drawn to an amine synergist including a tertiary benzylamine with a substituted benzene ring attached to a tertiary amine. The tertiary amine can be modified with multiple water soluble groups.
|
|
WO/2018/137558A1 |
The present disclosure relates to materials with strong circular dichroism (CD), circularly polarized luminescence (CPL), and high fluorescence quantum yield in the aggregate state and methods of preparation and use thereof.
|
|
WO/2018/122359A1 |
The present invention relates to a compound of the following formula (I). The invention also relates to uses thereof as a chromophore as such or for building pigments displaying special optical effects, including metal-like reflection.
|
|
WO/2018/119356A1 |
Methods for inhibiting transepithelial ion transport, inhibiting hydrocephalic development, and for treating hydrocephalus are disclosed herein. The methods include administering a potassium channel inhibitor to the individual. In one pa...
|
|
WO/2018/108992A2 |
The present invention relates to compounds of the formula (I), in particular to phenoxyphenylamidines of the formula (I), to a process for their preparation, to the use of phenoxyphenylamidines of the formula (I) according to the inventi...
|
|
WO/2018/107158A1 |
This present disclosure is directed to compounds of formula (I): where r, q, R1a, R1b, R1c, R1d, R1e, R2, R3, R4a, R5a, R5b, R6a, R6b, R8, and R9 are described herein, as single stereoisomers or as mixtures of stereoisomers, or pharmaceu...
|
|
WO/2018/098799A1 |
The present invention relates to a process for preparing a polyurethane foam by reacting a polyisocyanate with a polyol in the presence of a blow agent and a particular family of amine. The present invention also relates to a polyurethan...
|
|
WO/2018/090982A1 |
Provided are a benzodicycloalkane derivative, and a preparation method and use thereof. In particular, provided is a compound of formula (I), or a pharmaceutically acceptable salt, stereoisomer or solvate thereof, a preparation method th...
|
|
WO/2018/088797A1 |
The present invention relates to a spirobifluorene compound and a perovskite solar cell comprising the same and, more particularly, to a spirobifluorene compound which can be used as a hole transport material of a perovskite solar cell, ...
|
|
WO/2018/087064A1 |
The invention relates to a method for producing triarylorganoborates from organoboronic acid esters in the presence of an n-valent cation 1/n Kn+, comprising the anhydrous treatment of the reaction mixture, and to the use of the obtained...
|
|
WO/2018/084625A1 |
The present invention relates to a novel method for preparing (S)-N1-(2-aminoethyl)-3-(4-alkoxyphenyl)propane-1,2-diamine trihydrochloride.
|
|
WO/2018/071437A1 |
The disclosure provides methods for treating vulvovaginal atrophy (WA) and osteoporosis in breast cancer survivors and survivors of other malignancies with an effective amount of lasofoxifene, a pharmaceutically acceptable salt thereof, ...
|
|
WO/2018/062233A1 |
The present invention provides a compound represented by formula (I), which is usable as a cationic lipid facilitating the introduction of a nucleic acid into a cell, or the like, and a composition, or the like, containing the compound.
|
|
WO/2018/064231A1 |
Methods of treating ovarian cancer are disclosed.
|
|
WO/2018/051278A2 |
The present invention relates to a compound of formula (I) based on enamine derivatives and used as organic hole conductors or hole transporting material in an optoelectronic or photoelectrochemical device. The present invention relates ...
|
|
WO/2018/048932A1 |
Methods and compositions for use in treating, preventing or improving diseases related to the liver in an animal, including but not limited to nonalcoholic fatty liver disease (NAFLD), alcoholic liver disease (ALD) or nonalcoholic steato...
|
|
WO/2018/048319A1 |
The invention relates to chemical engineering processes, and more particularly to liquid-phase catalytic methods for producing, in the presence of hydrogen, alkylated para-phenetidine for use as a chemical substance or as a gasoline addi...
|
|
WO/2018/048320A1 |
The invention relates to chemical engineering processes, and more particularly to liquid-phase catalytic methods for producing, in the presence of hydrogen, alkylated para-anisidine for use as a chemical substance or as a gasoline additi...
|
|
WO/2018/033200A1 |
The present invention relates to ionic compounds containing an anion, and a cation having the following structural formula (1): R1R2R3N+-(|inker1)-O-(iinker2)-(FC) wherein: - R1 and R2 either linear or branched alkyl groups or together f...
|
|
WO/2018/021517A1 |
The present invention relates to a 4-alkoxy-3-(trifluoromethyl)benzyl alcohol production method with which it is possible to achieve a higher conversion rate and to closely control the generation of by-products by using DIBAL as a reduci...
|
|
WO/2018/022841A1 |
Disclosed herein are scavenging and antifouling compositions useful in applications relating to the production, transportation, storage, and separation of crude oil and natural gas. Also disclosed herein are methods of using the composit...
|
|
WO/2018/021526A1 |
A quaternary ammonium compound represented by formula (1). [(R1)m(R2)4-mN+]nXn- (1) (In the formula, each R1 independently represents an unsubstituted alkyl group or substituted alkyl group having 1-30 carbon atoms, an aryl group having ...
|
|
WO/2018/020263A1 |
The present invention provides compounds of the formula (I) and their use as Kv3 modulators.
|
|
WO/2018/018091A1 |
The present invention relates to compounds and their use in the prophylactic and/or therapeutic treatment of pulmonary fibrosis and/or related conditions.
|
|
WO/2017/067497A9 |
Disclosed are a monosubstituted or polysubstituted amphiphilic hypocrellin derivative, preparation method therefor, and uses thereof. In the present invention, the amphiphilic hypocrellin derivative having substituted functional groups s...
|
|
WO/2018/009720A1 |
Methods and compounds for use in promoting survival of at least one eukaryotic cell, wherein the compounds are effective as gamma-ketoaldehyde scavengers.
|
|
WO/2018/004945A1 |
A method of inhibiting the conversion of choline to trimethylamine (TMA) and lowering TMAO by providing a composition comprising a compound set forth in Formula (I):
|
|
WO/2017/216507A1 |
The invention relates to difluorocyclopropane compounds, methods for their manufacture, and their uses for example as medicaments. According to one aspect, there is provided a compound of general formula (I): wherein X and Y are phenyl g...
|
|
WO/2017/212059A1 |
The present invention relates to a new process of manufacturing of caged cyclofen-OH and derivatives thereof, of formula (I) or salts thereof, wherein n, R1, R1 ', R2, and R3 are as defined in the claims.
|
|
WO/2017/210371A2 |
Methods and small molecule compounds for inhibition of sodium channels are provided. One example of a class of compounds that may be used is represented by the compound of Formula (I) or a pharmaceutically acceptable salt, N-oxide or sol...
|
|
WO/2017/182097A1 |
The present invention relates an improved and well reproducible process for the preparation of Enclomiphene citrate having needle shaped crystal habit, and moreover, it is also related to a solid form of Enclomiphene citrate.
|
|
WO/2017/177326A1 |
The invention provides conjugates that comprise a targeting moiety, a nucleic acid, and optional linking groups as well as synthetic intermediates and synthetic methods useful for preparing the conjugates. The conjugates are useful to ta...
|
|
WO/2017/162476A1 |
An etheramine mixture comprising of at least one amine selected from the group consisting of amine of Formula (I) and amine of Formula (II) wherein R1-R12 are independently selected from H, alkyl, cycloalkyi, aryl, alkylaryl, or arylalky...
|
|
WO/2017/162477A1 |
An etheramine mixture comprising at least 90% by weight, based on the total weight of the etheramine mixture, of an amine of Formula (I) and/or (II), wherein R1-R12 are independently selected from H, alkyl, cycloalkyl, aryl, alkylaryl, o...
|
